SCHEMBL25197810

SCHEMBL25197810

COc1cc(B(O)O)ccc1S(=O)(=O)N(C)C1CCN(C)CC1

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 16/20 0.52
HTR2C P28335 16/20 0.52
L3MBTL1 Q9Y468 5/20 0.52
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.52
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30956781 1.00 HTR2A (0.52) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL25188793 0.82 HTR2A (0.55) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL6034623 0.78 HTR2A (0.72) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL25187258 0.72 HTR2A (0.44) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL30956782 0.72 HTR2A (0.44) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL6034633 0.71 HTR2A (0.60) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL25301879 0.70 ENPP2 (0.47) GAA
SCHEMBL6598163 0.69 HTR2A (0.60) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL25190283 0.68 HTR2A (0.40) HTR2AHTR2CL3MBTL1ALDH1A1GAA
SCHEMBL30989170 0.67 TSHR (0.48) ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201922-A Drak2 inhibitor and preparation method and application thereof 百极优棠(广东)医药科技有限公司 2024-06-14 CN disclosed
WO-2023083330-A1 DRAK2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 百极优棠(广东)医药科技有限公司 2023-05-19 WO disclosed
WO-2023083330-A1 DRAK2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 百极优棠(广东)医药科技有限公司 2023-05-19 WO disclosed